Resumen
Post-traumatic stress disorder (PTSD) is a mental disorder that may develop after exposure to exceptionally threatening or unescapable horrifying events. Actual therapies fail to alleviate the emotional suffering and cognitive impairment associated with this disorder, mostly because they are ineffective in treating the failure to extinguish trauma memories in a great percentage of those affected. In this review, current behavioral, cellular, and molecular evidence supporting the use of cotinine for treating PTSD are reviewed. The role of the positive modulation by cotinine of the nicotinic acetylcholine receptors (nAChRs) and their downstream effectors, the protection of astroglia, and the inhibition of microglia in the PTSD brain are also discussed.
Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 6700-6711 |
Número de páginas | 12 |
Publicación | Molecular Neurobiology |
Volumen | 55 |
N.º | 8 |
DOI | |
Estado | Publicada - 2018 |
Nota bibliográfica
Publisher Copyright:© 2018, Springer Science+Business Media, LLC, part of Springer Nature.
Áreas temáticas de ASJC Scopus
- Neurología
- Neurociencia celular y molecular